Richard G Wunderink

  • 18248 Citations
1984 …2024
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

My research interests revolve around understanding the risk factors, including host genetic risk, and improving outcomes of critically ill patients with serious infections. This includes severe community-acquired pneumonia, sepsis of all causes, and nosocomial infections, particularly ventilator-associated pneumonia.

Certifications and Licenses

Internal Medicine
Critical Care Medicine
Pulmonary Disease

Training Experience

1983Residency, Butterworth Hospital
1985Fellowship, Henry Ford Hospital

Education/Academic qualification

MD, Indiana University

… → 1980

Research interests

  • Chronic Infections
  • Critical Care
  • Critical Care Outcomes
  • Genetics: Medical
  • Immunologic and Infectious Disorders
  • Pneumonia
  • Respiratory Failure

Fingerprint Dive into the research topics where Richard G Wunderink is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
Pneumonia Medicine & Life Sciences
Ventilator-Associated Pneumonia Medicine & Life Sciences
Anti-Bacterial Agents Medicine & Life Sciences
Linezolid Medicine & Life Sciences
Artificial Respiration Medicine & Life Sciences
Bacterial Pneumonia Medicine & Life Sciences
Methicillin-Resistant Staphylococcus aureus Medicine & Life Sciences
Intensive Care Units Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2004 2024

Systems Analysis
Patient Care
Intensive Care Units
Quality of Life
training program

Research Output 1984 2019

3 Citations (Scopus)

A global priority list of the TOp TEn resistant Microorganisms (TOTEM) study at intensive care: a prioritization exercise based on multi-criteria decision analysis

Rello, J., Kalwaje Eshwara, V., Lagunes, L., Alves, J., Wunderink, R. G., Conway-Morris, A., Rojas, J. N., Alp, E. & Zhang, Z., Feb 4 2019, In : European Journal of Clinical Microbiology and Infectious Diseases. 38, 2, p. 319-323 5 p.

Research output: Contribution to journalArticle

Decision Support Techniques
Critical Care
Intensive Care Units

An international perspective on hospitalized patients with viral community-acquired pneumonia

the GLIMP Study Group, Feb 1 2019, In : European Journal of Internal Medicine. 60, p. 54-70 17 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Challenges in severe community-acquired pneumonia: a point-of-view review

Torres, A., Chalmers, J. D., Dela Cruz, C. S., Dominedò, C., Kollef, M., Martin-Loeches, I., Niederman, M. & Wunderink, R. G., Feb 27 2019, In : Intensive Care Medicine. 45, 2, p. 159-171 13 p.

Research output: Contribution to journalReview article

Anti-Bacterial Agents
Methicillin Resistance

Detection of respiratory pathogens in clinical samples using metagenomic shotgun sequencing

Qi, C., Hountras, P., Pickens, C. O., Walter, J. M., Kruser, J. M., Singer, B., Seed, P. C., Green, S. J. & Wunderink, R. G., Jul 1 2019, In : Journal of Medical Microbiology. 68, 7, p. 996-1002 7 p.

Research output: Contribution to journalArticle

Bronchoalveolar Lavage
18 Citations (Scopus)

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

Tsuji, B. T., Pogue, J. M., Zavascki, A. P., Paul, M., Daikos, G. L., Forrest, A., Giacobbe, D. R., Viscoli, C., Giamarellou, H., Karaiskos, I., Kaye, D., Mouton, J. W., Tam, V. H., Thamlikitkul, V., Wunderink, R. G., Li, J., Nation, R. L. & Kaye, K. S., Jan 1 2019, In : Pharmacotherapy. 39, 1, p. 10-39 30 p.

Research output: Contribution to journalArticle

Communicable Diseases
Polymyxin B